XHKG
0775
Market cap636mUSD
Oct 09, Last price
0.52HKD
1D
0.00%
1Q
-11.86%
Jan 2017
-24.64%
IPO
-72.18%
Name
CK Life Sciences Intl (Holdings) Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
CK Life Sciences International (Holdings), Inc. operates as an investment company, which engages in the business of research and development, manufacturing, commercialization, marketing and selling of products and assets in nutraceuticals, pharmaceuticals and agriculture related business. It operates through the following segments: Agriculture-Related and Health. The company was founded on August 10, 2001 and is headquartered in Hong Kong.
Key people
Mai Kuen Lee
Chief Manager - Human Resources and Administration · since 2018
Guo Li
Preclinical Development Director · since 2020
Patrick Mallon
Chief Operating Officer of Polynoma LLC
Chief Corporate Affairs Officer
Wai Yin Yan
Senior Manager - Internal Audit · since 2018
Company Secretary
Peter Tulloch
Non-Executive Director · since 2002
Independent Non-Executive Director · since 2015
Independent Non-Executive Director · since 2002
Independent Non-Executive Director · since 2020
Paul Tighe
Independent Non-Executive Director · since 2019
IPO date
Jul 16, 2002
Employees
1,887
Domiciled in
HK
Incorporated in
KY
Headquarters & legal address
c/o MAPLES CORPORATE SERVICES LIMITED, Ugland House, South Church Street, P. O. Box 309
George Town KY1-1104
KY
George Town KY1-1104
KY
Valuation
Title HKD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||